Exponent, Inc. (EXPO) Stock Price & How to Invest
Last updated July 2026
Short answer
Exponent (EXPO) is a high-margin, capital-light engineering and scientific consulting firm that companies and law firms hire for failure analysis, litigation support, and product risk work, so investors typically look at it as a durable, dividend-paying quality compounder that tends to trade at a premium multiple.
EXPO stock price
As of 2026-07-24, Exponent, Inc. (EXPO) last closed at $61.44, down 14.9% over the past year. Over the past 52 weeks it has traded between $53.67 and $79.79.
Prices are daily closing prices from Yahoo Finance and may be delayed. For the live quote, check your broker or Exponent, Inc.'s investor relations page. Walnut is informational, not investment advice.
What does Exponent, Inc. (EXPO) do?
Exponent, Inc. is a Menlo Park, California engineering and scientific consulting firm founded in 1967 that solves complex technical problems for corporations, law firms, insurers, and government agencies. Its two segments are Engineering and Other Scientific (roughly 85% of net revenues), covering failure analysis, product testing, user research, and disputes across consumer electronics, energy, utilities, transportation, and life sciences, and Environmental and Health (about 15%). The business is people-based rather than asset-based, so its economics revolve around billable hours, staff utilization, and realized billing rates, and its brand as a science-for-hire authority lets it command premium fees on reactive, high-stakes engagements.
For investors, Exponent is usually framed as a quality compounder: recurring demand tied to litigation, regulation, safety failures, and increasingly AI-enabled products supports steady mid-single to low-double-digit revenue growth, EBITDA margins near 28% of net revenues, and a shareholder-return model built on a growing dividend plus aggressive buybacks. The trade-off is that this quality is well recognized by the market, so the stock tends to carry a high earnings multiple that leaves limited room for disappointment if hiring, utilization, or billable-hour growth slows.
What's driving Exponent, Inc. (EXPO)?
1. Reactive and disputes demand
A large share of Exponent's work is reactive: product failures, accidents, recalls, and litigation that clients cannot defer. This countercyclical, event-driven demand across energy, life sciences, and consumer sectors gives the revenue base resilience and pricing power that generalist consultants lack.
2. AI-enabled products and new risk categories
Management has pointed to rising multidisciplinary work tied to artificial-intelligence-enabled products, autonomous systems, and connected devices. As new technologies create novel safety, reliability, and liability questions, Exponent's deep technical benches position it to win engagements that require credible independent expertise.
3. Utility risk management and infrastructure
Wildfire mitigation, grid hardening, and utility risk management have become durable demand drivers, alongside failure analysis in energy and transportation. These regulatory and safety-driven mandates support billable-hour growth and help offset softer discretionary consulting cycles.
4. Capital-light returns model
With minimal capital needs, Exponent converts profits into cash and returns most of it through a rising dividend and buybacks, including an expanded repurchase authorization in early 2026. Steady headcount growth plus improving utilization compounds per-share value over time.
What are the risks to Exponent, Inc. (EXPO)?
Exponent's output is entirely dependent on attracting and retaining specialized PhD-level and engineering talent, so wage inflation, attrition, or hiring shortfalls directly pressure capacity and margins. Utilization and billable hours can swing with client budgets and the timing of large disputes, making quarterly results lumpy. A meaningful portion of revenue is concentrated in a relatively small number of large engagements and clients, adding volatility. The stock also trades at a premium multiple (a trailing P/E in the low-to-mid 30s), so even modest growth disappointments can drive outsized share-price moves. Broader legal, regulatory, or economic slowdowns that reduce litigation and consulting spend would weigh on demand.
How is Exponent, Inc. (EXPO) valued? (approximate, JULY 2026)
A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Exponent, Inc.'s investor relations page or your broker.
- Revenue (TTM, gross): ~$580M
- Q1 2026 revenue: ~$166M (+14% YoY)
- Q1 2026 EPS (diluted): ~$0.59
- EBITDA margin (net rev.): ~28%
- Market cap: ~$2.8B
- Dividend yield: ~2%
Exponent's Q1 2026 revenue rose about 14% to roughly $166 million with net income up 11% to about $30 million, aided by 76% utilization and roughly 399,000 billable hours. The shares typically trade at a rich valuation, with a trailing P/E in the low-to-mid 30s, reflecting the market's view of the franchise as a durable, high-quality compounder. The company continues to return cash aggressively, paying dividends and repurchasing stock while expanding its buyback authorization.
Who competes with Exponent, Inc. (EXPO)?
Forensic and engineering consulting
Firms like Rimkus Consulting Group and various forensic engineering practices compete directly in failure analysis, accident reconstruction, and litigation support, though most operate at smaller scale or with less breadth than Exponent's multidisciplinary bench.
Broad professional services and disputes
FTI Consulting, J.S. Held, and disputes-and-investigations arms of larger advisory firms overlap with Exponent on litigation and risk work across energy, construction, and industrial sectors, competing more on management-consulting breadth than pure technical depth.
Specialized technical and regulatory services
Certara, ABS Group, and similar niche firms compete in specific areas such as life-sciences modeling, safety, and regulatory science, targeting slices of Exponent's Environmental and Health and engineering work.
How to invest in Exponent, Inc. (EXPO)
There are three common ways to get EXPO exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic basket, so EXPO sits alongside other stocks that express the same thesis.
Walnut takes the basket route. Describe a thesis where EXPO fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.
New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.
The bottom line on Exponent, Inc. (EXPO)
EXPO is a niche, brand-driven consulting franchise with strong margins and consistent capital returns, and its investment story hinges on billable-hour growth and utilization holding up against a rich valuation.
More on Exponent, Inc. (EXPO)
Whether EXPO is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is EXPO a buy?, and where the stock could go from here in the EXPO stock forecast.
For income investors, whether EXPO pays a dividend and how the payout looks is covered in does EXPO pay a dividend?
Build a basket around EXPO with Walnut
Use Exponent, Inc. as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
What does Exponent (EXPO) do?
+
Exponent is an engineering and scientific consulting firm that investigates why products, structures, and systems fail and provides expert analysis for litigation, product safety, and risk management. Clients include corporations, law firms, insurers, and government agencies across many industries.
How does Exponent make money?
+
It bills clients for the time of its scientists and engineers on a project basis, so revenue is driven by billable hours, staff utilization, and billing rates. It is a capital-light, people-based model with high margins and little need for heavy physical assets.
Is Exponent profitable?
+
Yes. Exponent is consistently profitable with EBITDA margins around 28% of net revenues. In Q1 2026 it reported net income of about $30 million and diluted EPS near $0.59, and it generates strong free cash flow.
Does Exponent pay a dividend?
+
Yes. Exponent pays a quarterly dividend that it has grown over time, with a yield of roughly 2%. It also returns significant cash through share buybacks and raised both its dividend and repurchase authorization in early 2026.
Why does EXPO trade at such a high P/E?
+
The market values Exponent as a durable, high-quality franchise with recurring, event-driven demand, strong margins, and steady capital returns. That reputation typically earns it a premium valuation, with a trailing P/E in the low-to-mid 30s as of mid-2026.
What are the main risks with Exponent stock?
+
Key risks include dependence on hiring and retaining specialized talent, quarter-to-quarter swings in utilization and billable hours, client and engagement concentration, and a rich valuation that leaves little cushion if growth slows or the litigation and consulting cycle softens.
How is Exponent exposed to AI and new technology?
+
Exponent benefits as AI-enabled products, autonomous systems, and connected devices create new safety, reliability, and liability questions. Its independent technical expertise positions it to advise on and investigate emerging technology risks, a growing source of demand cited by management.
Who competes with Exponent?
+
Competitors include forensic and engineering consultancies like Rimkus, broad advisory and disputes firms such as FTI Consulting and J.S. Held, and specialized technical or regulatory-science providers like Certara and ABS Group. Exponent differentiates on the depth and breadth of its scientific bench.
Walnut is informational, not investment advice. Financial figures on this page are approximations; always verify current numbers with Exponent, Inc.'s investor relations page or your broker before making investment decisions.